EUVIMEDEUVIMED entdecken
Multizentrische Studie

Safety and efficacy of salvage endoscopic submucosal dissection for Barrett’s neoplasia recurrence after radiofrequency ablation

Lauriane Mesureur, Pierre H Deprez iD, Raf Bisschops iD, Roos E Pouw, Bas L A M Weusten, Maximilien Barret, Pieter Dewint, David Tate, Philippe Leclercq, Stefan Seewald, Federico Barbaro, Francisco Baldaque-Silva iD und 11 weitere

Endoscopy · 01.09.2024 · 56 (09) · 653-662

DOI: 10.1055/a-2307-6949 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Endoscopy, erschienen am 01.09.2024. Verfasst von Lauriane Mesureur und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasme Hospital, HUB (Hôpital Universitaire de Bruxelles), Université…. Hauptthemen laut MEDLINE: Barrett Esophagus, Endoscopic Mucosal Resection, Salvage Therapy, Esophageal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study evaluated the safety and efficacy of salvage endoscopic submucosal dissection (ESD) for Barrett’s neoplasia recurrence after radiofrequency ablation (RFA).

Methods

Data from patients at 16 centers were collected for a multicenter retrospective study. Patients who underwent at least one RFA treatment for Barrett’s esophagus and thereafter underwent further esophageal ESD for neoplasia recurrence were included.

Results

Data from 56 patients who underwent salvage ESD between April 2014 and November 2022 were collected. Immediate complications included one muscular tear (1.8%) treated with stent (Agree classification: grade IIIa). Two transmural perforations (3.6%; treated with clips) and five muscular tears (8.9%; two treated with clips) had no clinical impact and were not considered as adverse events. Seven patients (12.5%) developed strictures (grade IIIa), which were treated with balloon dilation. Histological analysis showed 36 adenocarcinoma, 17 high grade dysplasia, and 3 low grade dysplasia. En bloc and R0 resection rates were 89.3% and 66.1%, respectively. Resections were curative in 33 patients (58.9%), and noncurative in 22 patients (39.3%), including 11 “local risk” (19.6%) and 11 “high risk” (19.6%) resections. At the end of follow-up with a median time of 14 (0–75) months after salvage ESD, and with further endoscopic treatment if necessary (RFA, argon plasma coagulation, endoscopic mucosal resection, ESD), neoplasia remission ratio was 37/53 (69.8%) and the median remission time was 13 (1–75) months.

Conclusion

In expert hands, salvage ESD was a safe and effective treatment for recurrence of Barrett’s neoplasia after RFA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusEndoscopic Mucosal ResectionSalvage TherapyEsophageal NeoplasmsNeoplasm Recurrence, LocalRadiofrequency AblationHumansMaleFemaleAgedRetrospective StudiesMiddle AgedAdenocarcinomaEsophageal StenosisAged, 80 and overTreatment OutcomeEsophagoscopy

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasme Hospital, HUB (Hôpital Universitaire de Bruxelles), Université Libres de Bruxelles (ULB), Brussels, Belgium.
  • Department of Hepatogastroenterology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Department of Gastroenterology and Hepatology, Universitair Ziekenhuis Leuven, Leuven, Belgium.
  • Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, location VUMC, Amsterdam, Netherlands.
  • Department of Gastroenterology and Hepatology, St Antonius hospital, Nieuwegein, Netherlands.
  • Department of Gastroenterology and Hepatology, UMC Utrecht, Utrecht University, Utrecht, Netherlands.

ORCID-Profile: Pierre H Deprez, Raf Bisschops, Francisco Baldaque-Silva, Arnaud Lemmers

Zitieren

APA

Mesureur, L., Deprez, P. H., Bisschops, R., Pouw, R. E., Weusten, B. L. A. M., Barret, M., Dewint, P., Tate, D., Leclercq, P., Seewald, S., Barbaro, F., Baldaque-Silva, F., Omae, M., Pioche, M., Figueiredo Ferreira, M., Bourke, M. J., Haidry, R., Snauwaert, C., Eisendrath, P., …, & Lemmers, A. (2024). Safety and efficacy of salvage endoscopic submucosal dissection for Barrett’s neoplasia recurrence after radiofrequency ablation. Endoscopy, 56(09), 653-662. https://doi.org/10.1055/a-2307-6949

Vancouver

Mesureur L, Deprez PH, Bisschops R, Pouw RE, Weusten BLAM, Barret M, et al. Safety and efficacy of salvage endoscopic submucosal dissection for Barrett’s neoplasia recurrence after radiofrequency ablation. Endoscopy. 2024;56(09):653-662. doi:10.1055/a-2307-6949

BibTeX
@article{Mesureur2024,
  author = {Mesureur, Lauriane and Deprez, Pierre H and Bisschops, Raf and Pouw, Roos E and Weusten, Bas L A M and Barret, Maximilien and Dewint, Pieter and Tate, David and Leclercq, Philippe and Seewald, Stefan and Barbaro, Federico and Baldaque-Silva, Francisco and Omae, Masami and Pioche, Mathieu and Figueiredo Ferreira, Mariana and Bourke, Michael J and Haidry, Rehan and Snauwaert, Christophe and Eisendrath, Pierre and De Maertelaer, Viviane and Rosewick, Nicolas and Devière, Jacques and Lemmers, Arnaud},
  title = {Safety and efficacy of salvage endoscopic submucosal dissection for Barrett’s neoplasia recurrence after radiofrequency ablation},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {09},
  pages = {653--662},
  doi = {10.1055/a-2307-6949}
}
Kostenlos starten →